Prosight Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-48,800
Closed -$1.91M 33
2018
Q2
$1.91M Buy
+48,800
New +$1.91M 1.4% 21